Aline Charabaty

1.5k citations
53 papers · 952 indexed · h-index 14
Topics
Inflammatory Bowel Disease (22 papers)Microscopic Colitis (19 papers)Cancer Immunotherapy and Biomarkers (9 papers)

In The Last Decade

Aline Charabaty

48 papers receiving 947 citations

Peers

Aline Charabaty
Comparison fields: 5 of 78
  • Oncology 660
  • Epidemiology 253
  • Immunology 196
  • Surgery 154
  • Genetics 137
Replace Maureen D. Moore with:
Maureen D. Moore United States
Judith A Strachan United Kingdom
Ciaran E. Redmond Ireland
Bo Vestergaard Pedersen Denmark
Megan Beems United States
Young Sook Park South Korea
Sarah Persing United States
Pragatheeshwar Thirunavukarasu United States
Adelle Atkinson Canada
Siân Jones United Kingdom
Aline Charabaty relative to Maureen D. Moore United States Maureen D. Moore's profile →
Citations per field
00.5×6.1×
Maureen D. Moore · 1×
Citations per year

Countries citing papers authored by Aline Charabaty

Since Specialization
Citations

This map shows the geographic impact of Aline Charabaty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Charabaty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Charabaty more than expected).

Fields of papers citing papers by Aline Charabaty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Charabaty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Charabaty. The network helps show where Aline Charabaty may publish in the future.

Co-authorship network of co-authors of Aline Charabaty

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Charabaty. A scholar is included among the top collaborators of Aline Charabaty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Charabaty. Aline Charabaty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 4
6 4
7 1
8 1
9 3
10 1
11 6
12 1
13 7
14 13
15 71
16 5
17 36
18 14
19 163
20 34

About Aline Charabaty

Aline Charabaty is a scholar working on Health, Genetics and Gastroenterology, having authored 53 papers that have together received 952 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (19 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Oncology (660 citations), Gastroenterology (68 citations) and Immunology (196 citations). Aline Charabaty has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Dana Alsaadi, Yinghong Wang, Faisal S. Ali, Mark Mattar, Hamzah Abu‐Sbeih, Rohan Mandaliya, Maham Farshidpour, Nidhi Malhotra, David M. Richards and Wenyi Luo. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology and Nature Reviews Gastroenterology & Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026